Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms

Br J Haematol. 2019 Nov;187(3):e69-e72. doi: 10.1111/bjh.16193. Epub 2019 Sep 16.

¹ Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
² Department of Oncology & Human Metabolism, The University of Sheffield, Sheffield, UK.
³ Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴ MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford and The Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁵ The Bateson Centre, Department of Biomedical Science, The University of Sheffield, Sheffield, UK.

No abstract available

Keywords: MPN10; inflammation; methotrexate; myeloproliferative neoplasms; symptoms.

Publication types